Advertisement
Screener

BIOGEN INC. (BIIB) Analyst Insights

RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$248.50(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$248.50High(m)Average(m)Low(m)2025-11-062026-11-06
DateStockAnalystFirmPrice When RatedPrice TargetUpside / DownsideRatingPerformance
2026-08-17BIIB
BIOGEN INC.
Laura ChicoWedbush Securities$209.83$215.00+2.46%Neutral
2026-07-28BIIB
BIOGEN INC.
Emily Field, CFABarclays$200.14$200.00-0.07%Equal Weight
2026-02-19BIIB
BIOGEN INC.
Emily Field, CFABarclays$195.62$185.00-5.43%Equal Weight
2024-11-29BIIB
BIOGEN INC.
Emily Field, CFABarclays$159.83Equal Weight
2024-10-30BIIB
BIOGEN INC.
Emily Field, CFABarclays$183.47$180.00-1.89%Equal Weight
2024-08-01BIIB
BIOGEN INC.
Emily Field, CFABarclays$213.20$190.00-10.88%Equal Weight
2024-04-24BIIB
BIOGEN INC.
Emily Field, CFABarclays$201.99$200.00-0.99%Equal Weight
2024-04-03BIIB
BIOGEN INC.
Emily Field, CFABarclays$206.38$215.00+4.18%Equal Weight
2024-02-15BIIB
BIOGEN INC.
Emily Field, CFABarclays$223.35$230.00+2.98%Equal Weight
2023-11-08BIIB
BIOGEN INC.
Emily Field, CFABarclays$231.69$255.00+10.06%Equal Weight

Similar stocks

Stock NameCountryMarket CapPE Ratio
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29